GlassScriptPhysician profile
Michael W Colgrove
NPI 1548474240
$685.40
in general payments reported to CMS, 2019-2025
14 companies · $83.22 in 2025
The $83.22 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.75 · 2020: $45.04 · 2021: $38.00 · 2022: $142 · 2023: $191 · 2024: $143 · 2025: $83.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $417.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $142.25 | 2019-2024 | |
| Hologic Sales and Service, LLC | $126.42 | 2019-2025 | Myosure Tissue Removal Device, Novasure, Aptima |
| Minerva Surgical, INC | $91.69 | 2022-2023 | |
| Organon LLC | $90.86 | 2022-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $50.93 | 2021-2022 | |
| Exeltis, USA INC. | $30.15 | 2024-2025 | Slynd |
| Novo Nordisk INC | $27.58 | 2020 | |
| Astellas Pharma US INC | $24.35 | 2024 | Veozah |
| Ethicon US, LLC | $19.93 | 2024 | Enseal |
| Bayer Healthcare Pharmaceuticals INC. | $18.33 | 2024 | |
| Abbvie INC. | $17.46 | 2020 | |
| Becton, Dickinson and Company | $17.23 | 2025 | Bd Onclarity |
| Scynexis, INC. | $17.01 | 2022 | |
| Allergan, INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Colgrove listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.